J. Guevara-Patiño

发表

HSP70iQ435A-Encoding DNA Repigments Vitiligo Lesions in Sinclair Swine.

A. Rademaker, A. Salzman, I. L. Le Poole, 2018, The Journal of investigative dermatology.

HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.

I. L. Le Poole, J. Klarquist, J. McCracken, 2008, The Journal of investigative dermatology.

Lourdes Plaza-Rojas, J. Guevara-Patiño, 2021, Frontiers in Immunology.

DNA Immunization against Tissue-Restricted Antigens Enhances Tumor Immunity after Allogeneic Hemopoietic Stem Cell Transplantation1

J. Wolchok, M. Perales, M. V. D. van den Brink, 2006, The Journal of Immunology.

TransplantationAllogeneic Hemopoietic Stem Cell Antigens Enhances Tumor Immunity after DNA Immunization against Tissue-Restricted

J. Wolchok, M. Perales, A. Houghton, 2006 .

HSP70i is a critical component of the immune response leading to vitiligo

I. L. Le Poole, J. Klarquist, A. Zloza, 2012, Pigment cell & melanoma research.

Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo

M. Nishimura, S. Mehrotra, E. Garrett-Mayer, 2013, Science Translational Medicine.

HSP70iQ435A to subdue autoimmunity and support anti-tumor responses

I. L. Le Poole, E. Dellacecca, C. Cosgrove, 2021, Cell Stress and Chaperones.

Optimization of a self antigen for presentation of multiple epitopes in cancer immunity.

J. Wolchok, A. Houghton, T. Merghoub, 2006, The Journal of clinical investigation.

Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells

A. Houghton, José A. Guevara-Patiño, M. Turk, 2004, The Journal of experimental medicine.

Barriers and Opportunities for CAR T-Cell Targeting of Solid Tumors

José A. Guevara-Patiño, J. Conejo-Garcia, J. Guevara-Patiño, 2022, Immunological investigations.

Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death.

P. Thomas, A. Lasfar, H. Kaufman, 2016, Cell reports.

Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy

Kushal Prajapati, Lourdes Beatriz Plaza Rojas, C. Pérez, 2018, Cellular & Molecular Immunology.

Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFβ

N. Dulin, A. Zloza, Jeremy A. O’Sullivan, 2023, International journal of molecular sciences.

Multiple pathways to tumor immunity and concomitant autoimmunity

J. Wolchok, A. Houghton, S. M. Goldberg, 2002, Immunological reviews.

T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma

M. Schell, Xuefeng Wang, S. Yoder, 2022, Journal for ImmunoTherapy of Cancer.

CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma.

J. Wolchok, D. Scheinberg, A. Houghton, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

CD 8 + T-Cell – Dependent Immunity Following Xenogeneic DNA Immunization against CD 20 in a Tumor Challenge Model of B-Cell Lymphoma

J. Wolchok, D. Scheinberg, A. Houghton, 2004 .

Enhanced Responses to Tumor Immunization Following Total Body Irradiation Are Time-Dependent

Vanessa M. Hubbard-Lucey, J. Wolchok, M. Perales, 2013, PloS one.

Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine Model

T. Kuzel, A. Zloza, J. Reiser, 2022, Diagnostics.

Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction

Kushal Prajapati, E. Henry, Alex C. Belshoff, 2020, Frontiers in Oncology.

Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity

J. Wolchok, A. Houghton, José A. Guevara-Patiño, 2003, Oncogene.

Autoimmunity and tumor immunity induced by immune responses to mutations in self

A. Houghton, B. Kappel, José A. Guevara-Patiño, 2006, Nature Medicine.

Priming with very low-affinity peptide ligands gives rise to CD8+ T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression

N. Dulin, A. Zloza, T. Moore, 2011, Cancer Immunology, Immunotherapy.

CD8 Co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression

M. Nishimura, A. Zloza, Jeremy A. O’Sullivan, 2011, Cancer Immunology, Immunotherapy.

Lentivector Immunization Stimulates Potent CD8 T Cell Responses against Melanoma Self-Antigen Tyrosinase-Related Protein 1 and Generates Antitumor Immunity in Mice1

D. Munn, Yukai He, N. Fu, 2009, The Journal of Immunology.

Generates Antitumor Immunity in Mice Self-Antigen Tyrosinase-Related Protein 1 CD 8 T Cell Responses against Melanoma Lentivector Immunization Stimulates Potent

D. Munn, Yukai He, José A. Guevara-Patiño, 2009 .

Development of Tumor-Infiltrating CD8+ T Cell Memory Precursor Effector Cells and Antimelanoma Memory Responses Are the Result of Vaccination and TGF-β Blockade during the Perioperative Period of Tumor Resection

M. Posner, E. Bellavance, J. McCracken, 2011, The Journal of Immunology.

Comparison of Two Cancer Vaccines Targeting Tyrosinase: Plasmid DNA and Recombinant Alphavirus Replicon Particles

Maureen F. Maughan, J. Wolchok, M. Perales, 2005, Clinical Cancer Research.

NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses

P. Thomas, J. Schenkel, A. Sperling, 2011, Nature Medicine.

Mosenson Mutant HSP 70 Reverses Autoimmune Depigmentation in Vitiligo

M. Nishimura, S. Mehrotra, E. Garrett-Mayer, 2013 .

CD8+ T Cells Sabotage Their Own Memory Potential through IFN-γ–Dependent Modification of the IL-12/IL-15 Receptor α Axis on Dendritic Cells

D. Cole, J. McCracken, A. Zloza, 2012, The Journal of Immunology.

Modification of the IL-12 / IL-15 Receptor Dependent − γ Potential through IFN-T Cells Sabotage Their Own Memory + CD 8

D. Cole, J. McCracken, A. Zloza, 2012 .

Combination of epitope-optimized DNA vaccination and passive infusion of monoclonal antibody against HER2/neu leads to breast tumor regression in mice.

J. Wolchok, A. Houghton, T. Merghoub, 2011, Vaccine.

Epitope‐optimized alpha‐fetoprotein genetic vaccines prevent carcinogen‐induced murine autochthonous hepatocellular carcinoma

D. Munn, L. Butterfield, Z. Guo, 2014, Hepatology.

Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+T cells and autoimmune vitiligo

A. Zloza, José A. Guevara-Patiño, T. Moore, 2011, Autoimmunity.

Mechanisms of immunization against cancer using chimeric antigens.

J. Wolchok, A. Houghton, C. Ferrone, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes.

J. Wolchok, A. Houghton, P. Gregor, 2007, Vaccine.

Immune recognition of self in immunity against cancer.

A. Houghton, J. Guevara-Patiño, 2004, The Journal of clinical investigation.

A Single Heteroclitic Epitope Determines Cancer Immunity After Xenogeneic DNA Immunization Against a Tumor Differentiation Antigen1

Jonathan J. Lewis, J. Wolchok, A. Houghton, 2003, The Journal of Immunology.

Differentiation Antigen Immunization Against a Tumor Cancer Immunity After Xenogeneic DNA A Single Heteroclitic Epitope Determines

Jonathan J. Lewis, J. Wolchok, A. Houghton, 2003 .

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.

J. Wolchok, H. Scher, J. Allison, 2004, Vaccine.

Immunity to cancer through immune recognition of altered self: studies with melanoma.

J. Wolchok, A. Houghton, José A. Guevara-Patiño, 2003, Advances in cancer research.

Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice

D. Munn, Yukai He, N. Fu, 2009, The Journal of Immunology.

Cancer Immunity, Vol. 5, p. 2 (1 February 2005)

A. Viale, J. Wolchok, A. Houghton, 2005 .

Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics.

A. Viale, C. Antonescu, J. Wolchok, 2005, Cancer immunity.

Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens

Peisheng Zhang, S. Sakaguchi, V. Jacobs, 2011, The Journal of Immunology.

I. Messaoudi, J. Nikolich-Žugich, J. LeMaoult, 2004, The Journal of experimental medicine.

CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting

M. Nishimura, R. Orentas, Yueying Liu, 2010, Cancer Immunology, Immunotherapy.

NKG2D signaling certifies effector CD8 T cells for memory formation

N. Zeleznik-Le, Kushal Prajapati, José A. Guevara-Patiño, 2019, Journal of Immunotherapy for Cancer.

NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells.

A. Zloza, T. Moore, Jeremy A. O’Sullivan, 2023, Molecular immunology.

Emerging monoclonal antibody therapies in the treatment of metastatic urothelial carcinoma

G. Sonpavde, Xuefeng Wang, R. Jain, 2023, Expert opinion on emerging drugs.

It Takes Two to Tango.

José A. Guevara-Patiño, Lourdes Plaza-Rojas, J. Guevara-Patiño, 2020, The Journal of investigative dermatology.

A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.

P. Pisa, R. Andersen, C. Leder, 2009, Vaccine.

EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma

Ritu Chaudhary, Xuefeng Wang, J. Conejo-Garcia, 2023, Cancer research communications.

Antibody–Drug Conjugates in the Treatment of Urothelial Cancer

G. Sonpavde, Xuefeng Wang, R. Jain, 2023, BioDrugs.

Priming with very low affinity peptide ligands gives rise to CD8+ T cell effectors with enhanced function but with greater susceptibility to TGF{beta}-mediated suppression

N. Dulin, A. Zloza, T. Moore, 2011 .

EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma

Ritu Chaudhary, Xuefeng Wang, J. Conejo-Garcia, 2023, Cancer research communications.

NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses

J. Schenkel, A. Sperling, B. Polić, 2012, Nature Medicine.

Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy

Kushal Prajapati, Brianna Burke, Kushal Prajapati, 2018, Cellular & Molecular Immunology.

Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens

Peisheng Zhang, S. Sakaguchi, V. Jacobs, 2011, The Journal of Immunology.

HSP70i is a critical component of the immune response leading to vitiligo

I. L. Le Poole, J. Klarquist, A. Zloza, 2012, Pigment cell & melanoma research.

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

Justin C. Boucher, M. Maus, Bishwas Shrestha, 2023, Molecular therapy oncolytics.

Resection during the Perioperative Period of Tumor Blockade β Result of Vaccination and TGF-Antimelanoma Memory Responses Are the Cell Memory Precursor Effector Cells and T + Development of Tumor-Infiltrating CD 8

M. Posner, E. Bellavance, J. McCracken, 2011 .